APO Research
Talk to an analyst

APO RESEARCH · REPORT

Urine Drug Testing Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Urine Drug Testing Service Market Analysis and Forecast 2026-2032

16 April 2026191 pages

Choose your research edition.

Industry ResearchUrine Drug Testing Service Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Urine Drug Testing Service Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Urine Drug Testing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Urine Drug Testing Service Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Urine Drug Testing Service Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Urine Drug Testing Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Urine Drug Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Urine Drug Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Urine Drug Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Urine Drug Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Urine Drug Testing Service include Abbott, Labcorp, Quest Diagnostics, Millennium Health, Genesis Reference Labs, Concentra, DISA, Medigold Health and Keystone Laboratories, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Urine Drug Testing Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Urine Drug Testing Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Urine Drug Testing Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Urine Drug Testing Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Urine Drug Testing Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Urine Drug Testing Service revenue, projected growth trends, production technology, application and end-user industry.

Urine Drug Testing Service Segment by Company

Abbott

Labcorp

Quest Diagnostics

Millennium Health

Genesis Reference Labs

Concentra

DISA

Medigold Health

Keystone Laboratories

Crystal Health

MedTox

Australian Clinical Labs

Dominion Diagnostics

Matrix Diagnostics

Dorevitch Pathology

Urine Drug Testing Service Segment by Type

On-site Testing

Laboratory-based Testing

Urine Drug Testing Service Segment by Application

Hospital

Clinic

Others

Urine Drug Testing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Urine Drug Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Urine Drug Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Urine Drug Testing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Urine Drug Testing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Urine Drug Testing Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Urine Drug Testing Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Urine Drug Testing Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. On-site Testing Major Player Table 3. Laboratory-based Testing Major Player Table 4. Global Urine Drug Testing Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Clinic Major Player Table 7. Others Major Player Table 8. Urine Drug Testing Service Industry Trends Table 9. Urine Drug Testing Service Industry Drivers Table 10. Urine Drug Testing Service Industry Opportunities and Challenges Table 11. Urine Drug Testing Service Industry Restraints Table 12. Global Urine Drug Testing Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Urine Drug Testing Service Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Urine Drug Testing Service Market Share by Region (2021-2026) Table 15. Global Urine Drug Testing Service Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Urine Drug Testing Service Market Share by Region (2027-2032) Table 17. Global Urine Drug Testing Service Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Urine Drug Testing Service Revenue Market Share by Players (2021-2026) Table 19. Global Urine Drug Testing Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Urine Drug Testing Service Key Players Headquarters & Area Served Table 21. Global Urine Drug Testing Service Players, Product Type & Application Table 22. Global Urine Drug Testing Service Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Urine Drug Testing Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Urine Drug Testing Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Urine Drug Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Urine Drug Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Urine Drug Testing Service Revenue Market Share by Type (2021-2026) Table 29. Global Urine Drug Testing Service Revenue Market Share by Type (2027-2032) Table 30. Global Urine Drug Testing Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Urine Drug Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Urine Drug Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Urine Drug Testing Service Revenue Market Share by Application (2021-2026) Table 34. Global Urine Drug Testing Service Revenue Market Share by Application (2027-2032) Table 35. Abbott Company Information Table 36. Abbott Business Overview Table 37. Abbott Urine Drug Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Abbott Urine Drug Testing Service Product Portfolio Table 39. Abbott Recent Development Table 40. Labcorp Company Information Table 41. Labcorp Business Overview Table 42. Labcorp Urine Drug Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Labcorp Urine Drug Testing Service Product Portfolio Table 44. Labcorp Recent Development Table 45. Quest Diagnostics Company Information Table 46. Quest Diagnostics Business Overview Table 47. Quest Diagnostics Urine Drug Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Quest Diagnostics Urine Drug Testing Service Product Portfolio Table 49. Quest Diagnostics Recent Development Table 50. Millennium Health Company Information Table 51. Millennium Health Business Overview Table 52. Millennium Health Urine Drug Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Millennium Health Urine Drug Testing Service Product Portfolio Table 54. Millennium Health Recent Development Table 55. Genesis Reference Labs Company Information Table 56. Genesis Reference Labs Business Overview Table 57. Genesis Reference Labs Urine Drug Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Genesis Reference Labs Urine Drug Testing Service Product Portfolio Table 59. Genesis Reference Labs Recent Development Table 60. Concentra Company Information Table 61. Concentra Business Overview Table 62. Concentra Urine Drug Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Concentra Urine Drug Testing Service Product Portfolio Table 64. Concentra Recent Development Table 65. DISA Company Information Table 66. DISA Business Overview Table 67. DISA Urine Drug Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. DISA Urine Drug Testing Service Product Portfolio Table 69. DISA Recent Development Table 70. Medigold Health Company Information Table 71. Medigold Health Business Overview Table 72. Medigold Health Urine Drug Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Medigold Health Urine Drug Testing Service Product Portfolio Table 74. Medigold Health Recent Development Table 75. Keystone Laboratories Company Information Table 76. Keystone Laboratories Business Overview Table 77. Keystone Laboratories Urine Drug Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Keystone Laboratories Urine Drug Testing Service Product Portfolio Table 79. Keystone Laboratories Recent Development Table 80. Crystal Health Company Information Table 81. Crystal Health Business Overview Table 82. Crystal Health Urine Drug Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Crystal Health Urine Drug Testing Service Product Portfolio Table 84. Crystal Health Recent Development Table 85. MedTox Company Information Table 86. MedTox Business Overview Table 87. MedTox Urine Drug Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. MedTox Urine Drug Testing Service Product Portfolio Table 89. MedTox Recent Development Table 90. Australian Clinical Labs Company Information Table 91. Australian Clinical Labs Business Overview Table 92. Australian Clinical Labs Urine Drug Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Australian Clinical Labs Urine Drug Testing Service Product Portfolio Table 94. Australian Clinical Labs Recent Development Table 95. Dominion Diagnostics Company Information Table 96. Dominion Diagnostics Business Overview Table 97. Dominion Diagnostics Urine Drug Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Dominion Diagnostics Urine Drug Testing Service Product Portfolio Table 99. Dominion Diagnostics Recent Development Table 100. Matrix Diagnostics Company Information Table 101. Matrix Diagnostics Business Overview Table 102. Matrix Diagnostics Urine Drug Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Matrix Diagnostics Urine Drug Testing Service Product Portfolio Table 104. Matrix Diagnostics Recent Development Table 105. Dorevitch Pathology Company Information Table 106. Dorevitch Pathology Business Overview Table 107. Dorevitch Pathology Urine Drug Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Dorevitch Pathology Urine Drug Testing Service Product Portfolio Table 109. Dorevitch Pathology Recent Development Table 110. North America Urine Drug Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 111. North America Urine Drug Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 112. North America Urine Drug Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 113. North America Urine Drug Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 114. North America Urine Drug Testing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. North America Urine Drug Testing Service Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Urine Drug Testing Service Revenue by Country (US$ Million) & (2027-2032) Table 117. Europe Urine Drug Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 118. Europe Urine Drug Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 119. Europe Urine Drug Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 120. Europe Urine Drug Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 121. Europe Urine Drug Testing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe Urine Drug Testing Service Revenue by Country (2021-2026) & (US$ Million) Table 123. Europe Urine Drug Testing Service Revenue by Country (US$ Million) & (2027-2032) Table 124. China Urine Drug Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 125. China Urine Drug Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 126. China Urine Drug Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 127. China Urine Drug Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 128. Asia Urine Drug Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 129. Asia Urine Drug Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 130. Asia Urine Drug Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 131. Asia Urine Drug Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 132. Asia Urine Drug Testing Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Asia Urine Drug Testing Service Revenue by Region (US$ Million) & (2021-2026) Table 134. Asia Urine Drug Testing Service Revenue by Region (US$ Million) & (2027-2032) Table 135. SAMEA Urine Drug Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 136. SAMEA Urine Drug Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 137. SAMEA Urine Drug Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 138. SAMEA Urine Drug Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 139. SAMEA Urine Drug Testing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. SAMEA Urine Drug Testing Service Revenue by Country (2021-2026) & (US$ Million) Table 141. SAMEA Urine Drug Testing Service Revenue by Country (US$ Million) & (2027-2032) Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Urine Drug Testing Service Image Figure 2. Global Urine Drug Testing Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Urine Drug Testing Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. On-site Testing Image Figure 5. Laboratory-based Testing Image Figure 6. Global Urine Drug Testing Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Urine Drug Testing Service Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Others Image Figure 11. Global Urine Drug Testing Service Market Size (US$ Million) & (2021-2032) Figure 12. Global Urine Drug Testing Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Urine Drug Testing Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Urine Drug Testing Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Urine Drug Testing Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Urine Drug Testing Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Urine Drug Testing Service Revenue Market Share by Type (2021-2032) Figure 19. Global Urine Drug Testing Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Urine Drug Testing Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Urine Drug Testing Service Revenue Market Share by Application (2021-2032) Figure 22. North America Urine Drug Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Urine Drug Testing Service Revenue Share by Type (2021-2032) Figure 24. North America Urine Drug Testing Service Revenue Share by Application (2021-2032) Figure 25. North America Urine Drug Testing Service Revenue Share by Country (2021-2032) Figure 26. United States Urine Drug Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Urine Drug Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Urine Drug Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Urine Drug Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Urine Drug Testing Service Revenue Share by Type (2021-2032) Figure 31. Europe Urine Drug Testing Service Revenue Share by Application (2021-2032) Figure 32. Europe Urine Drug Testing Service Revenue Share by Country (2021-2032) Figure 33. Germany Urine Drug Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Urine Drug Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Urine Drug Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Urine Drug Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Urine Drug Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Urine Drug Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Urine Drug Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Urine Drug Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Urine Drug Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Urine Drug Testing Service Revenue Share by Type (2021-2032) Figure 43. China Urine Drug Testing Service Revenue Share by Application (2021-2032) Figure 44. Asia Urine Drug Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Urine Drug Testing Service Revenue Share by Type (2021-2032) Figure 46. Asia Urine Drug Testing Service Revenue Share by Application (2021-2032) Figure 47. Asia Urine Drug Testing Service Revenue Share by Region (2021-2032) Figure 48. Japan Urine Drug Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Urine Drug Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Urine Drug Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Urine Drug Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Urine Drug Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Urine Drug Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Urine Drug Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Urine Drug Testing Service Revenue Share by Type (2021-2032) Figure 56. SAMEA Urine Drug Testing Service Revenue Share by Application (2021-2032) Figure 57. SAMEA Urine Drug Testing Service Revenue Share by Country (2021-2032) Figure 58. Brazil Urine Drug Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Urine Drug Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Urine Drug Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Urine Drug Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Urine Drug Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Urine Drug Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Urine Drug Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Urine Drug Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Urine Drug Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Urine Drug Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Urine Drug Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • On-site Testing
  • Laboratory-based Testing
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Abbott
  • Labcorp
  • Quest Diagnostics
  • Millennium Health
  • Genesis Reference Labs
  • Concentra
  • DISA
  • Medigold Health
  • Keystone Laboratories
  • Crystal Health
  • MedTox
  • Australian Clinical Labs
  • Dominion Diagnostics
  • Matrix Diagnostics
  • Dorevitch Pathology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Urine Drug Testing Service Market by Type
  3. 1.2.1 Global Urine Drug Testing Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 On-site Testing
  5. 1.2.3 Laboratory-based Testing
  6. 1.3 Urine Drug Testing Service Market by Application
  7. 1.3.1 Global Urine Drug Testing Service Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Urine Drug Testing Service Market Dynamics
  1. 2.1 Urine Drug Testing Service Industry Trends
  2. 2.2 Urine Drug Testing Service Industry Drivers
  3. 2.3 Urine Drug Testing Service Industry Opportunities and Challenges
  4. 2.4 Urine Drug Testing Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Urine Drug Testing Service Market Perspective (2021-2032)
  2. 3.2 Global Urine Drug Testing Service Growth Trends by Region
  3. 3.2.1 Global Urine Drug Testing Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Urine Drug Testing Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Urine Drug Testing Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Urine Drug Testing Service Revenue by Players
  2. 4.1.1 Global Urine Drug Testing Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Urine Drug Testing Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Urine Drug Testing Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Urine Drug Testing Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Urine Drug Testing Service Key Players Headquarters & Area Served
  7. 4.4 Global Urine Drug Testing Service Players, Product Type & Application
  8. 4.5 Global Urine Drug Testing Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Urine Drug Testing Service Market CR5 and HHI
  11. 4.6.3 2025 Urine Drug Testing Service Tier 1, Tier 2, and Tier 3
5 Urine Drug Testing Service Market Size by Type
  1. 5.1 Global Urine Drug Testing Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Urine Drug Testing Service Revenue by Type (2021-2032)
  3. 5.3 Global Urine Drug Testing Service Revenue Market Share by Type (2021-2032)
6 Urine Drug Testing Service Market Size by Application
  1. 6.1 Global Urine Drug Testing Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Urine Drug Testing Service Revenue by Application (2021-2032)
  3. 6.3 Global Urine Drug Testing Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Abbott
  2. 7.1.1 Abbott Company Information
  3. 7.1.2 Abbott Business Overview
  4. 7.1.3 Abbott Urine Drug Testing Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Urine Drug Testing Service Product Portfolio
  6. 7.1.5 Abbott Recent Developments
  7. 7.2 Labcorp
  8. 7.2.1 Labcorp Company Information
  9. 7.2.2 Labcorp Business Overview
  10. 7.2.3 Labcorp Urine Drug Testing Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Labcorp Urine Drug Testing Service Product Portfolio
  12. 7.2.5 Labcorp Recent Developments
  13. 7.3 Quest Diagnostics
  14. 7.3.1 Quest Diagnostics Company Information
  15. 7.3.2 Quest Diagnostics Business Overview
  16. 7.3.3 Quest Diagnostics Urine Drug Testing Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Quest Diagnostics Urine Drug Testing Service Product Portfolio
  18. 7.3.5 Quest Diagnostics Recent Developments
  19. 7.4 Millennium Health
  20. 7.4.1 Millennium Health Company Information
  21. 7.4.2 Millennium Health Business Overview
  22. 7.4.3 Millennium Health Urine Drug Testing Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Millennium Health Urine Drug Testing Service Product Portfolio
  24. 7.4.5 Millennium Health Recent Developments
  25. 7.5 Genesis Reference Labs
  26. 7.5.1 Genesis Reference Labs Company Information
  27. 7.5.2 Genesis Reference Labs Business Overview
  28. 7.5.3 Genesis Reference Labs Urine Drug Testing Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Genesis Reference Labs Urine Drug Testing Service Product Portfolio
  30. 7.5.5 Genesis Reference Labs Recent Developments
  31. 7.6 Concentra
  32. 7.6.1 Concentra Company Information
  33. 7.6.2 Concentra Business Overview
  34. 7.6.3 Concentra Urine Drug Testing Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Concentra Urine Drug Testing Service Product Portfolio
  36. 7.6.5 Concentra Recent Developments
  37. 7.7 DISA
  38. 7.7.1 DISA Company Information
  39. 7.7.2 DISA Business Overview
  40. 7.7.3 DISA Urine Drug Testing Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 DISA Urine Drug Testing Service Product Portfolio
  42. 7.7.5 DISA Recent Developments
  43. 7.8 Medigold Health
  44. 7.8.1 Medigold Health Company Information
  45. 7.8.2 Medigold Health Business Overview
  46. 7.8.3 Medigold Health Urine Drug Testing Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Medigold Health Urine Drug Testing Service Product Portfolio
  48. 7.8.5 Medigold Health Recent Developments
  49. 7.9 Keystone Laboratories
  50. 7.9.1 Keystone Laboratories Company Information
  51. 7.9.2 Keystone Laboratories Business Overview
  52. 7.9.3 Keystone Laboratories Urine Drug Testing Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Keystone Laboratories Urine Drug Testing Service Product Portfolio
  54. 7.9.5 Keystone Laboratories Recent Developments
  55. 7.10 Crystal Health
  56. 7.10.1 Crystal Health Company Information
  57. 7.10.2 Crystal Health Business Overview
  58. 7.10.3 Crystal Health Urine Drug Testing Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Crystal Health Urine Drug Testing Service Product Portfolio
  60. 7.10.5 Crystal Health Recent Developments
  61. 7.11 MedTox
  62. 7.11.1 MedTox Company Information
  63. 7.11.2 MedTox Business Overview
  64. 7.11.3 MedTox Urine Drug Testing Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 MedTox Urine Drug Testing Service Product Portfolio
  66. 7.11.5 MedTox Recent Developments
  67. 7.12 Australian Clinical Labs
  68. 7.12.1 Australian Clinical Labs Company Information
  69. 7.12.2 Australian Clinical Labs Business Overview
  70. 7.12.3 Australian Clinical Labs Urine Drug Testing Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Australian Clinical Labs Urine Drug Testing Service Product Portfolio
  72. 7.12.5 Australian Clinical Labs Recent Developments
  73. 7.13 Dominion Diagnostics
  74. 7.13.1 Dominion Diagnostics Company Information
  75. 7.13.2 Dominion Diagnostics Business Overview
  76. 7.13.3 Dominion Diagnostics Urine Drug Testing Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Dominion Diagnostics Urine Drug Testing Service Product Portfolio
  78. 7.13.5 Dominion Diagnostics Recent Developments
  79. 7.14 Matrix Diagnostics
  80. 7.14.1 Matrix Diagnostics Company Information
  81. 7.14.2 Matrix Diagnostics Business Overview
  82. 7.14.3 Matrix Diagnostics Urine Drug Testing Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Matrix Diagnostics Urine Drug Testing Service Product Portfolio
  84. 7.14.5 Matrix Diagnostics Recent Developments
  85. 7.15 Dorevitch Pathology
  86. 7.15.1 Dorevitch Pathology Company Information
  87. 7.15.2 Dorevitch Pathology Business Overview
  88. 7.15.3 Dorevitch Pathology Urine Drug Testing Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Dorevitch Pathology Urine Drug Testing Service Product Portfolio
  90. 7.15.5 Dorevitch Pathology Recent Developments
8 North America
  1. 8.1 North America Urine Drug Testing Service Revenue (2021-2032)
  2. 8.2 North America Urine Drug Testing Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Urine Drug Testing Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Urine Drug Testing Service Revenue by Type (2027-2032)
  5. 8.3 North America Urine Drug Testing Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Urine Drug Testing Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Urine Drug Testing Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Urine Drug Testing Service Revenue by Application (2027-2032)
  9. 8.5 North America Urine Drug Testing Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Urine Drug Testing Service Revenue by Country
  11. 8.6.1 North America Urine Drug Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Urine Drug Testing Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Urine Drug Testing Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Urine Drug Testing Service Revenue (2021-2032)
  2. 9.2 Europe Urine Drug Testing Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Urine Drug Testing Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Urine Drug Testing Service Revenue by Type (2027-2032)
  5. 9.3 Europe Urine Drug Testing Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Urine Drug Testing Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Urine Drug Testing Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Urine Drug Testing Service Revenue by Application (2027-2032)
  9. 9.5 Europe Urine Drug Testing Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Urine Drug Testing Service Revenue by Country
  11. 9.6.1 Europe Urine Drug Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Urine Drug Testing Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Urine Drug Testing Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Urine Drug Testing Service Revenue (2021-2032)
  2. 10.2 China Urine Drug Testing Service Revenue by Type (2021-2032)
  3. 10.2.1 China Urine Drug Testing Service Revenue by Type (2021-2026)
  4. 10.2.2 China Urine Drug Testing Service Revenue by Type (2027-2032)
  5. 10.3 China Urine Drug Testing Service Revenue Share by Type (2021-2032)
  6. 10.4 China Urine Drug Testing Service Revenue by Application (2021-2032)
  7. 10.4.1 China Urine Drug Testing Service Revenue by Application (2021-2026)
  8. 10.4.2 China Urine Drug Testing Service Revenue by Application (2027-2032)
  9. 10.5 China Urine Drug Testing Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Urine Drug Testing Service Revenue (2021-2032)
  2. 11.2 Asia Urine Drug Testing Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Urine Drug Testing Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Urine Drug Testing Service Revenue by Type (2027-2032)
  5. 11.3 Asia Urine Drug Testing Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Urine Drug Testing Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Urine Drug Testing Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Urine Drug Testing Service Revenue by Application (2027-2032)
  9. 11.5 Asia Urine Drug Testing Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Urine Drug Testing Service Revenue by Country
  11. 11.6.1 Asia Urine Drug Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Urine Drug Testing Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Urine Drug Testing Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Urine Drug Testing Service Revenue (2021-2032)
  2. 12.2 SAMEA Urine Drug Testing Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Urine Drug Testing Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Urine Drug Testing Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Urine Drug Testing Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Urine Drug Testing Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Urine Drug Testing Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Urine Drug Testing Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Urine Drug Testing Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Urine Drug Testing Service Revenue by Country
  11. 12.6.1 SAMEA Urine Drug Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Urine Drug Testing Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Urine Drug Testing Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst